Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.17
Delayed Data
As of Apr 28
 +0.06 / +1.46%
Today’s Change
1.83
Today|||52-Week Range
13.90
+114.95%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close4.11
Today’s open4.08
Day’s range3.95 - 4.22
Volume169,667
Average volume (3 months)684,271
Market cap$41.2M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...-0.06-8.72%
CBLICleveland Biolabs In...-0.08-2.22%
XBIOXenetic Biosciences ...+0.12+2.58%
MTEXMannatech Inc-0.45-2.80%
Data as of 3:59pm ET, 04/28/2017

Financials

Last reporting dateMarch 28, 2017
EPS forecast (this quarter)-$3.15
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts